Pharmaceutical company Amanta Healthcare Limited made a positive debut on the stock markets today, September 9, 2025. The stock listed at ₹135 on the NSE, about 7.14% higher than its issue price of ₹126. On the BSE, it opened at ₹134.90, showing a similar premium.
This debut was in line with market expectations, as analysts had predicted a modest 5–8% listing gain based on the company’s grey market premium (GMP).
9 Sept 2025
NSE (also listed on BSE)
₹120 – ₹126
₹126 crore (fresh issue ~1 crore shares)
₹135
~7.1% over ₹126
82.6×
Retail 55× • NII 209× • QIB 36×
~₹9 (signalling ~7% gain)
Pharmaceuticals (sterile liquid products)
The heavy demand showed strong confidence in the company, which makes sterile liquid products and has a growing presence in the healthcare sector.
Amanta’s debut comes at a time when Indian markets are trading near record highs, with Nifty 50 around 24,850 and Sensex above 81,000, led by IT and healthcare stocks. Investors are also showing increasing interest in healthcare IPOs, which are seen as defensive plays with strong long-term growth potential.
What Investors Should Watch
- Short-term trend: Stocks that list at a premium often see profit booking on the first day. Investors will watch if Amanta can hold above the ₹135 mark.
- Liquidity: With strong demand in IPO, the stock may see high trading volumes in the first week.
- Sector impact: A successful debut may boost sentiment for upcoming pharma and healthcare IPOs.
Amanta Healthcare’s listing at a 7% premium reflects strong investor demand and healthy IPO subscription. The real test now will be whether the stock can sustain gains in the coming sessions.
Investor Tip: Those who got allotment already see listing gains. New buyers should watch price stability and volume trends before entering.
Explore More on Amanta Healthcare & Stock Market Tools
Get official price data, filings, and disclosures for Amanta Healthcare on NSE. Plus, check out exclusive stock analysis tools on eBharat.com to track markets better.
